---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-246364"
form_type: "8-K"
ticker: "PLRX"
cik: "0001746473"
company_name: "PLIANT THERAPEUTICS, INC."
filed_at: "2022-09-16T23:59:59+00:00"
generated_at: "2026-06-23T09:09:17.723011+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Pliant Therapeutics appoints Katharine Knobil to Board, amends bylaws

## Summary
- Dr. Katharine Knobil appointed to newly created Board seat; term expires at 2025 annual meeting.
- Knobil will serve on R&D Committee; qualifies as independent director.
- She receives option for 30,000 shares vesting over 3 years, annual retainer $39,000 prorated.
- Board approved Second Amended and Restated Bylaws with enhanced shareholder proposal requirements and emergency procedures.

## SEC filing metadata
- accession: 0001193125-22-246364
- form_type: 8-K
- ticker: PLRX
- cik: 0001746473
- company_name: PLIANT THERAPEUTICS, INC.
- filed_at: 2022-09-16T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1746473/000119312522246364/0001193125-22-246364-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1746473/000119312522246364/d400254d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-246364
- JSON: https://secwatch.observer/filing/0001193125-22-246364.json
- Plain text: https://secwatch.observer/filing/0001193125-22-246364.txt

## Key facts
- Executive change
  Katharine Knobil was appointed as Director at PLIANT THERAPEUTICS, INC..
  - Action: appointed
  - Role: Director
  source text: the Board of Directors (the “Board”) of Pliant Therapeutics, Inc. (the “Company”) appointed, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, Dr. Katharine Knobil to fill a newly created Board seat
  evidence_url: https://www.sec.gov/Archives/edgar/data/1746473/000119312522246364/0001193125-22-246364-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.